SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
134 hedge funds and large institutions have $418M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 60 increasing their positions, 30 reducing their positions, and 17 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 30
59% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 17
9% more capital invested
Capital invested by funds: $385M → $418M (+$33M)
6% more funds holding
Funds holding: 127 → 134 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$10.1M |
| 2 |
HM
HealthCor Management
New York
|
+$7.87M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$5.51M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$3.54M |
| 5 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$3.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
-$16.8M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$14.2M |
| 3 |
State Street
Boston,
Massachusetts
|
-$9.98M |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$2.72M |
| 5 |
Public Employees Retirement Association of Colorado
Denver,
Colorado
|
-$2.35M |
SGNT Hedge Fund Activity: Q4 2015 in Review
134 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2015, worth a combined $418M — up 8.6% from $385M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new SGNT positions and 17 closed out — a net gain of 10 holders — while 60 added to existing stakes and 30 trimmed.
The largest buyer was Eagle Asset Management, adding an estimated $10.1M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $16.8M sold.
- 134 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2015, up from 127 in Q3 2015.
- Funds reported $418M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2015, up 8.6% quarter-over-quarter.
- 27 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2015 and 17 closed out, a net change of +10 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2015 was Eagle Asset Management, an estimated $10.1M added.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2015 was Scopia Capital Management, an estimated $16.8M sold.
Based on aggregated 13F filings for Q4 2015.